- Meredith has cratered terribly as a result of the combination of the Time M&A with the COVID-19 pandemic and the resulting drop in advertising revenues.
- The company from some perspectives looks to be in a very bad spot, but things aren't as bad as they look.
- I wouldn't consider MDP to be a "BUY" compared to most other companies available at better safeties, but Meredith offers undeniable upside both in terms of capital appreciation and dividends.
- I'm holding onto my 0.3% position and expect rewards in the future, but the investment seen from a comparative basis was nonetheless a bad one at its time. Learn from it.
For further details see:
I'm Holding Onto My Meredith Shares - Here's Why